会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method for quantitative determination of 1,5-anhydroglucitol
    • 1,5-脱水葡萄糖醇定量测定方法
    • US6153419A
    • 2000-11-28
    • US930709
    • 1997-10-16
    • Kazuo AisakaSakae TazoeKatsuhiko AndoKeiko Ochiai
    • Kazuo AisakaSakae TazoeKatsuhiko AndoKeiko Ochiai
    • C12N9/24C12Q1/34C12Q1/48
    • C12Q1/34C12N9/2402C12Q1/48C12Y302/01028G01N2333/355G01N2333/924Y10S435/872
    • The present invention relates to a method for quantitative determination of 1,5-anhydroglucitol in a sample, which comprises mixing the sample and an enzyme having activity that is inhibited by 1,5-anhydroglucitol in a concentration-dependent manner, and measuring the activity of the enzyme; and a reagent for quantitative determination of 1,5-anhydroglucitol which comprises an enzyme having activity that is inhibited by 1,5-anhydroglucitol in a concentration-dependent manner, a substrate for the enzyme, and a reagent for quantitative determination of a product formed by the enzyme activity. The present invention also relates to novel trehalase having a Ki value of 0.33 mM or less for 1,5-anhydroglucitol; and a process for producing novel trehalase having the above-mentioned physicochemical properties, which comprises culturing in a medium a microorganism belonging to the genus Nocardia and capable of producing the trehalase, and recovering the trehalase from the culture.
    • PCT No.PCT / JP97 / 00440 Sec。 371日期:1997年10月16日 102(e)1997年10月16日PCT PCT 1997年2月19日PCT公布。 公开号WO97 / 31103 日期:1997年8月28日本发明涉及一种样品中1,5-脱水葡萄糖醇的定量测定方法,该方法包括以浓度依赖性方式将样品与具有1,5-脱水葡萄糖醇抑制活性的酶 ,并测定酶的活性; 以及用于定量测定1,5-脱水葡萄糖醇的试剂,该试剂含有以浓度依赖性方式被1,5-脱水葡萄糖醇抑制的活性的酶,酶底物和定量产物形成试剂 通过酶活性。 本发明还涉及1,5-脱水葡萄糖醇的Ki值为0.33mM以下的新型海藻糖酶; 以及具有上述物理化学性质的新型海藻糖酶的制造方法,其包括在培养基中培养属于诺卡氏菌属的微生物并能够生产海藻糖酶,并从培养物中回收海藻糖酶的方法。
    • 5. 发明授权
    • Bacillus strains which produce HMG-CoA reductase inhibitors
    • 产生HMG-CoA还原酶抑制剂的芽孢杆菌菌株
    • US06468780B2
    • 2002-10-22
    • US09829080
    • 2001-04-10
    • Yutaka TakanoMasaru HasegawaHideo MoriKatsuhiko AndoKeiko OchiaiHiroaki MotoyamaAkio Ozaki
    • Yutaka TakanoMasaru HasegawaHideo MoriKatsuhiko AndoKeiko OchiaiHiroaki MotoyamaAkio Ozaki
    • C12N120
    • C12R1/07C12P7/62C12P17/06
    • Disclosed is a process for producing a compound represented by general formula (II-a): (wherein R1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, or an alkali metal; and R2 represents a substituted or unsubstituted alkyl or aryl group) [hereinafter referred to as Compound (II-a)] or the lactone form of Compound (II-a) [hereinafter referred to as Compound (II-b)] which comprises subjecting a compound represented by general formula (I-a): (wherein R1 represents a hydrogen atom, a substituted or unsubstituted alkyl group, or an alkali metal; and R2 represents a substituted or unsubstituted alkyl or aryl group) [hereinafter referred to as Compound (I-a)] or the lactone form of Compound (I-a) [hereinafter referred to as Compound (I-b)] to the action of an enzyme source derived from a microorganism belonging to the genus Bacillus and capable of converting Compound (I-a) or Compound (I-b) into Compound (II-a) or Compound (II-b) in a reaction mixture to form Compound (II-a) or Compound (II-b) in the reaction mixture, and recovering Compound (II-a) or Compound (II-b) from the reaction mixture.
    • 公开了一种制备由通式(II-a)表示的化合物的方法:其中R 1表示氢原子,取代或未取代的烷基或碱金属; R 2表示取代或未取代的烷基或芳基) [化学式(II-a)]或化合物(II-a)的内酯形式[以下称为化合物(II-b)]] [其中包括使通式(Ia)表示的化合物 R1表示氢原子,取代或未取代的烷基或碱金属; R2表示取代或未取代的烷基或芳基)[以下称为化合物(Ia)]或化合物(Ia)的内酯形式[ (Ia)或化合物(Ib)转化为化合物(II-a)或化合物(II-a)的酶源的作用,以下称为化合物(Ib) b)在反应混合物中形成化合物(II -a)或化合物(II-b),并从反应混合物中回收化合物(II-a)或化合物(II-b)。